Balaxi Pharma receives WHO-GMP certification for Hyderabad facility
BALAXI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Balaxi Pharmaceuticals received WHO-GMP certification for its first pharmaceutical formulation manufacturing facility located at Jadcherla, Hyderabad, Telangana. The certification was issued by the Licensing Authority, Government of Telangana on 27th August, 2026 after inspection on 14th July, 2026, and is valid until 26th August, 2029. Manufacturing of initial approved products has already commenced, with plans to progressively add more products and expand the portfolio for target international markets.
Strengthens manufacturing credentials, enables expansion into international regulated markets, positive for long-term revenue potential.